Hide
Show all
Email this article Treatment of Hyperhidrosis and its Impact on Quality of Life: Literature Review
Abstract
Background: Hyperhidrosis is considered a condition characterized by excessive, unmanageable sweating. The disease can deteriorate the quality of life from a psychological,
emotional, and social perspective. Hyperhidrosis is a challenging condition that interferes with routine activities, causes emotional imbalance, and disturbs both the professional and social lives of the patients.
Aim: The aim of the study is to review and summarize published literature on hyperhidrosis, quality of life, degree of severity, and comparison of treatment methods of hyperhidrosis.
Method: We have searched all the available literature via PubMed and Google Scholar databases by using keywords hyperhidrosis prevalence, quality of life, hyperhidrosis disease severity scale, and hyperhidrosis treatments.
Conclusion: the published literature clarifies that hyperhidrosis affects the patients’ quality of life. There are a variety of methods for the treatment of primary hyperhidrosis, but comparative effectiveness is lacking. The signification of this study is to provide a new method of treatment that would be more effective for the treatment of primary hyperhidrosis.
Keywords
Full Text:
PDFReferences
Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016 Dec 15;308(10):743–9.
Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016 Dec;75(6):1126–33.
Hamm H. Impact of Hyperhidrosis on Quality of Life and its Assessment. Dermatol Clin. 2014;32(4):467–76.
Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I. Prevalence and Disease Burden of Hyperhidrosis in the Adult Population. Dermatology. 2013;227(1):10–3.
Nyamekye I. Current Therapeutic Options for Treating Primary Hyperhidrosis. Eur J Vasc Endovasc Surg. 2004 Jun;27(6):571–6.
Sehgal V. Diagnosis and Treatment of Common Skin Diseases . Jaypee Brothers Medical Publishers (P) Ltd.; 2017.
Hasimoto EN, Cataneo DC, Reis TA dos, Cataneo AJM. Hyperhidrosis: prevalence and impact on quality of life. J Bras Pneumol. 2018 Jul 30;44(4):292–8.
Liu Y, Bahar R, Kalia S, Huang RY, Phillips A, Su M, et al. Hyperhidrosis Prevalence and Demographical Characteristics in Dermatology Outpatients in Shanghai and Vancouver. Wang J, editor. PLoS One. 2016 Apr 22;11(4):e0153719.
Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241–8.
Gelbard CM, Epstein H, Hebert A. Primary Pediatric Hyperhidrosis: A Review of Current Treatment Options. Pediatr Dermatol [Internet]. 2008 Nov;25(6):591–8.
Shayesteh A, Janlert U, Brulin C, Boman J, Nylander E. Prevalence and Characteristics of Hyperhidrosis in Sweden: A Cross-Sectional Study in the General Population. Dermatology [Internet]. 2016;232(5):586–91.
Ribeiro Santos Morard M, Betanho Martins R, Lopes Ribeiro AC, Guimarães Rocha Lima P, dos Santos Carvalho B, Junior JCBS. Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro. Samy AM, editor. PLoS One. 2019 Sep 13;14(9):e0220664.
Fujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: From questionnaire analysis. J Dermatol . 2013 Nov;40(11):886–90.
Walling HW. Clinical differentiation of primary from secondary hyperhidrosis. J Am Acad Dermatol 2011 Apr;64(4):690–5.
bolognia, dermatology) jean l bolognia md, joseph l jorizzo md julie v schaffer md dermatology 2 v.
Haider A. Focal hyperhidrosis: diagnosis and management. Can Med Assoc J. 2005 Jan 4;172(1):69–75.
de Paula Loureiro M, de Campos JRM, Wolosker N, Kauffman P. Hyperhidrosis: A Complete Guide to Diagnosis and Management. Springer. 2018. 281 p.
Kamudoni P, Mueller B, Halford J, Schouveller A, Stacey B, Salek MS. The impact of hyperhidrosis on patients’ daily life and quality of life: A qualitative investigation. Health Qual Life Outcomes. 2017;15(1):1–10.
International hyperhidrosis society. https://www.sweathelp.org/
N. J. Lowe, A. Campanati, I. Bodokh et al., “The place of botulinum toxin type A in the treatment of focal hyperhidrosis,” British Journal of Dermatology, vol. 151, no. 6, pp. 1115–1122 2004.
Lenefsky M, Rice ZP. Hyperhidrosis and its impact on those living with it. Am J Manag Care. 2018;24(23):S491–5.
Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. British Journal of Dermatology. 2008 Nov;159(5):997-1035.
Solish N, Bertucci V, Dansereau A, HONG HC, Lynde C, Lupin M, Smith KC, Storwick G. A comprehensive approach to the recognition, diagnosis, and severity‐based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatologic Surgery. 2007 Aug;33(8):908-23.
Doft MA, Hardy KL, Ascherman JA. Treatment of Hyperhidrosis With Botulinum Toxin. Aesthetic Surg J. 2012 Feb 1;32(2):238–44.
Tubert-Brohman I, Sherman W, Repasky M, Beuming T. Improved docking of polypeptides with Glide. Journal of chemical information and modeling. 2013 Jul 22;53(7):1689-99.
Sriraam LM, Sundaram R, Ramalingam R, Ramalingam KK. Minor’s Test: Objective Demonstration of Horner’s Syndrome. Indian J Otolaryngol Head Neck Surg. 2015 Jun 30;67(2):190–2.
Skiveren J, Larsen H, Kjaerby E, Larsen R. The Influence of Needle Size on Pain Perception in Patients Treated with Botulinum Toxin A Injections for Axillary Hyperhidrosis. Acta Derm Venereol. 2011;91(1):72–4.
del Boz J, Padilla-España L, Segura-Palacios JM. Técnica de infiltración de toxina botulínica en hiperhidrosis axilar. Actas Dermosifiliogr. 2014 Jun;105(5):517–8.
Abtahi-Naeini B, Nilforoushzadeh M, Najafian J, Naeini Ff, Pourazizi M. A novel option for treatment of primary axillary hyperhidrosis: Fractionated microneedle radiofrequency. J Postgrad Med. 2015;61(2):141.
Alster TS, Lupton JR. Nonablative cutaneous remodeling using radiofrequency devices. Clinics in dermatology. 2007 Sep 1;25(5):487-91.
Cho SI, Chung BY, Choi MG, Baek JH, Cho HJ, Park CW, et al. Evaluation of the Clinical Efficacy of Fractional Radiofrequency Microneedle Treatment in Acne Scars and Large Facial Pores. Dermatologic Surg. 2012 Jul;38(7):1017–24.
Refbacks
ISSN: 2346-8491 (online)